Genetic risk predictors have important potential implications for clinical medicine, because they identify individuals at risk before the condition has manifested. For example, individuals with high polygenic score for heart attack derive the greatest benefit from preventive medications such as cholesterol lowering therapy and those with the highest polygenic scores for breast cancer may benefit from earlier and more intensive mammography screening (Natarajan et al., 2017; Pharoah et al., 2008).
